Nonablative hematopoietic cell transplantation for the treatment of metastatic renal cell carcinoma. [electronic resource]
Producer: 20030731Description: 805-12 p. digitalISSN:- 0268-3369
- Antineoplastic Agents -- therapeutic use
- Carcinoma, Renal Cell -- immunology
- Clinical Trials as Topic
- Combined Modality Therapy
- Cyclophosphamide
- Cytokines -- therapeutic use
- Graft Survival
- Graft vs Host Disease -- etiology
- Graft vs Tumor Effect
- Humans
- Immunotherapy, Adoptive
- Kidney Neoplasms -- immunology
- Melphalan
- Multicenter Studies as Topic
- Nephrectomy
- Peripheral Blood Stem Cell Transplantation -- adverse effects
- Recombinant Proteins -- therapeutic use
- Survival Analysis
- Thiotepa
- Transplantation Chimera
- Transplantation Conditioning -- methods
- Treatment Outcome
- Vidarabine -- analogs & derivatives
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.